Should physicians go out of the way to differentiate between acute hepatitis B and acute exacerbation of chronic hepatitis B?

키워드

참고문헌 (20)

1. Sujata Lall, "The dilemma of differentiating between acute hepatitis B and chronic hepatitis B with acute exacerbation: Is quantitative serology the answer?", Clinical and Molecular Hepatology, 26(2), pp.187~195 (2020), 대한간학회
2. Pondé RA, "Acute hepatitis B virus infection or acute exacerbation of chronic hepatitis B infection : the differential serological diagnosis", Eur J Clin Microbiol Infect Dis, 35, pp.29~40 (2016)
3. European Association for the Study of the Liver, "EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection", J Hepatol, 67, pp.370~398 (2017)
4. Sarin SK, "Asian-Pacific clinical practice guidelines on the management of hepatitis B : a 2015 update", Hepatol Int, 10, pp.1~98 (2016)
5. Terrault NA, "Update on prevention, diagnosis, and treatment of chronic hepatitis B : AASLD 2018 hepatitis B guidance", Hepatology, 67, pp.1560~1599 (2018)
6. Korean Association for the Study of the Liver (KASL), "KASL clinical practice guidelines for management of chronic hepatitis B", Clinical and Molecular Hepatology, 25(2), pp.93~159 (2019), 대한간학회
7. Dao DY, "Two distinct subtypes of hepatitis B virus-related acute liver failure are separable by quantitative serum immunoglobulin M anti-hepatitis B core antibody and hepatitis B virus DNA levels", Hepatology, 55, pp.676~684 (2012)
8. Huang YW, "Higher cut-off index value of immunoglobulin M antibody to hepatitis B core antigen in Taiwanese patients with hepatitis B", J Gastroenterol Hepatol, 21, pp.859~862 (2006)
9. Kumar M, "Differentiating acute hepatitis B from the first episode of symptomatic exacerbation of chronic hepatitis B", Dig Dis Sci, 51, pp.594~599 (2006)
10. Han Y, "Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare", J Gastroenterol Hepatol, 23, pp.1728~1733 (2008)
11. Rodella A, "Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B", J Clin Virol, 37, pp.206~212 (2006)
12. Park JW, "Differentiation of acute and chronic hepatitis B in IgM anti-HBc positive patients", World J Gastroenterol, 21, pp.3953~3959 (2015)
13. Gerlich WH, "Cutoff levels of immunoglobulin M antibody against viral core antigen for differentiation of acute, chronic, and past hepatitis B virus infections", J Clin Microbiol, 24, pp.288~293 (1986)
14. Hong S, "Antibodysecreting cells with a phenotype of Ki-67low, CD138high, CD31high, and CD38high secrete nonspecific IgM during primary hepatitis A virus infection", J Immunol, 191, pp.127~134 (2013)
15. Hazell SL, "Clinical utility of avidity assays", Expert Opin Med Diagn, 1, pp.511~519 (2007)
16. Terkmani H, "Anti-HBc antibody avidity determination allows rapid discrimination between acute hepatitis B and hepatitis B reactivation", Hepatology, 42, pp.717A~718A (2005)
17. Frösner GG, "Diagnostic significance of quantitative determination of hepatitis B surface antigen in acute and chronic hepatitis B infection", Eur J Clin Microbiol, 1, pp.52~58 (1982)
18. Chulanov VP, "Kinetics of HBV DNA and HBsAg in acute hepatitis B patients with and without coinfection by other hepatitis viruses", J Med Virol, 69, pp.313~323 (2003)
19. Rehermann B, "Immune responses in hepatitis B virus infection", Semin Liver Dis, 23, pp.21~38 (2003)
20. Brahmania M, "Association between severe serum alanine aminotransferase flares and hepatitis B e antigen seroconversion and HBV DNA decrease in untreated patients with chronic HBV infection", Clin Gastroenterol Hepatol, 17, pp.2541~2551.e2 (2019)

관련 논문AI추천